Facebook
X
LinkedIn
Forward| Title | Credit |
Series date |
Member price | Non-member price |
|---|---|---|---|---|
|
2024 National Conference on Pediatric Health Care Bundle SAVE You get 24 courses from NAPNAP's 2024 National Conference totaling 27 NAPNAP Contact Hours, 5.5 Pharmacology,1.25 Psychopharmacology and 2.5 Controlled Substance. This continuing education activity is offered at a member-only discounted rate of $199, a cost-savings of more than $60. Non-members may purchase this bundle for $500. Join NAPNAP before purchasing to save more than $300. |
06/30/2024 to 06/30/2026 | $199.00 | $500.00 | |
|
Obsessive-compulsive, tics and related disorders 1.0 NAPNAP Contact Hours, including 0.25 Psychopharmacology hours. This continuing education activity is part of NAPNAP Cares and is offered at a reduced rate to NAPNAP members. This continuing education activity rate is $10 for NAPNAP members. For non-members, this continuing education activity rate is $20. This course will discuss the evaluation, diagnostic decision making, and initial- and ongoing- management of Obsessive-compulsive, tics and related disorders. |
|
06/17/2024 to 06/30/2026 | $10.00 | $20.00 |
|
Stop Child Trafficking in Your Community: Become an ACT Advocate (2024) 1.5 NAPNAP Contact Hours. This continuing education activity rate is $15 for NAPNAP Members and $30 for non- members. This life-saving, innovative workshop and leadership opportunity is specifically developed for pediatric focused NPs to learn about child trafficking, methods of identification and referral and, most importantly, prevention. There are more people enslaved in labor and/or sex trafficking than at any point in history, meaning children of all socio-economic profiles are at risk with some populations more vulnerable than others. Alliance for Children in Trafficking (ACT) Advocates will receive a certificate of recognition as a trained expert who will then be able to deliver this unique content to health care professionals and lay people in your community. |
|
03/21/2024 to 06/30/2026 | $15.00 | $30.00 |
|
Bipolar and related disorders 1.25 NAPNAP Contact Hours, including 0.5 Psychopharmacology hours. This continuing education activity is part of NAPNAP Cares and is offered at a reduced rate to NAPNAP members. This continuing education activity is $12.5 for NAPNAP members. For non-members, this continuing education activity rate is $25. This course will discuss the evaluation, diagnostic decision making, and initial- and ongoing- management of Bipolar and related disorders. |
|
06/17/2024 to 06/30/2026 | $12.50 | $25.00 |
|
Advancing Care for Pediatric Neurodevelopmental Disorders: A Comprehensive Overview 1.25 NAPNAP Contact Hours. This continuing education activity is part of NAPNAP Cares and is offered at a reduced rate to NAPNAP members. This continuing education activity rate is $12.5 for NAPNAP members. For non-members, this continuing education activity rate is $25. This course will discuss the evaluation, diagnostic decision making, and initial- and ongoing- management of Advancing Care for Pediatric Neurodevelopmental Disorders. |
|
06/17/2024 to 06/30/2026 | $12.50 | $25.00 |
|
Neonatal Opioid Withdrawal Syndrome 1.0 NAPNAP Contact Hours, including 0.25 Psychopharmacology hours and 1.00 Controlled substance hours. This continuing education activity is part of NAPNAP Cares and is offered at a reduced rate to NAPNAP members. This continuing education activity rate is $10 for NAPNAP members. For non-members, this continuing education activity rate is $20. This course will discuss the evaluation, diagnostic decision making, and initial- and ongoing- management of Neonatal Opioid Withdrawal Syndrome. |
|
06/17/2024 to 06/30/2026 | $10.00 | $20.00 |
|
Neurosensory Impairments and Mental/Developmental Disorders Related to Medical Conditions 1.00 NAPNAP Contact Hour. This continuing education activity is part of NAPNAP Cares and is offered at a reduced rate to NAPNAP members. This continuing education activity rate is $10 for NAPNAP members. For non-members, this continuing education activity rate is $20. This course will discuss the evaluation, diagnostic decision making, and initial- and ongoing- management of Neurosensory Impairments and Mental/ Developmental Disorders Related to Medical Conditions. |
|
06/17/2024 to 06/30/2026 | $10.00 | $20.00 |
|
Mental Health and Emergencies 1.25 NAPNAP Contact Hour of which 0.25 is pharmacology content. This continuing education activity is part of NAPNAP Cares and is offered at a reduced rate to NAPNAP members. This continuing education activity rate is $12.5 for NAPNAP members. For non-members, this continuing education activity rate is $25. This course will discuss emergency care and mental health. |
|
06/17/2024 to 06/30/2026 | $12.50 | $25.00 |
|
Epilepsy in Children 1.00 NAPNAP Contact Hour of which 0.25 is pharmacology content. This continuing education activity is part of NAPNAP Cares and is offered at a reduced rate to NAPNAP members. This continuing education activity rate is $10 for NAPNAP members. For non-members, this continuing education activity rate is $20. This course will discuss the evaluation, diagnostic decision making, and initial- and ongoing- management of Epilepsy in children. . |
|
06/17/2024 to 06/30/2026 | $10.00 | $20.00 |
|
Addressing Challenges in the Recognition and Management of Pediatric Sepsis in the Emergency Department, Critical Care and Post-Sepsis Care 1.0 NAPNAP Contact Hour of which 0.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is a recorded presentation for NAPNAP's 2024 National Conference. Sepsis remains one of the most frequent causes of pediatric morbidity and mortality. This presentation will address challenges in pediatric sepsis recognition and management, as well as provide education regarding care of the septic patient in various settings (e.g., emergency department, critical care, and post-sepsis care). Participants will be introduced to sepsis protocols currently being utilized within institutions across the country. |
|
06/27/2024 to 06/30/2026 | $10.00 | $20.00 |
|
JPHC CE: Diagnosis and Management of Pediatric Allergic Rhinoconjunctivitis in the US 1.0 NAPNAP contact hour of which 0.5 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Allergic rhinoconjunctivitis (AR/C) is a common pediatric condition. The physical, emotional, and social burden of AR/C in children highlights the need for accurate diagnosis with optimal treatment. This review provides practical information on the diagnosis and management of pediatric AR/C. Key features of the patient history and physical exam needed to diagnose seasonal and perennial AR/C are covered. Various AR/C treatment options are reviewed such as allergen avoidance, pharmacotherapies, and allergy immunotherapy (both subcutaneous injections and sublingual tablets) as well as their mode of action, side effects, and their role in guideline-recommended therapy. Practical information such as pollen calendars, management algorithms, and treatment product characteristics have also been included in this review. J Pediatr Health Care. (2025) 39, 489-502. |
|
05/01/2025 to 06/30/2026 | $0.00 | $10.00 |
|
JPHC CE: The Resurgence of Syphilis: A Critical Public Health Concern 1.25 NAPNAP contact hour of which 0.5 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Syphilis, a sexually transmitted infection caused by Treponema pallidum, has become a concerning resurgence in recent years, particularly in the United States. Of significant concern is the steep rise in congenital syphilis cases, which poses grave risks to maternal and neonatal health. This article provides an overview of the epidemiology, risk factors, clinical manifestations, screening methods, and treatment strategies for syphilis, with a specific focus on congenital transmission. Drawing upon current literature and guidelines, the paper underscores the importance of early detection and intervention to prevent adverse outcomes associated with congenital syphilis. Furthermore, the article highlights the challenges in syphilis diagnosis, including the interpretation of serological tests and the management of neurosyphilis. Recommendations for practice, including screening protocols and treatment regimens, are discussed in detail. The conclusion emphasizes the urgent need for collaborative efforts among healthcare providers, public health agencies, and community stakeholders to address the syphilis epidemic effectively. By adhering to evidence-based guidelines and leveraging available resources, clinicians can play a pivotal role in reducing the burden of syphilis and safeguarding the health of vulnerable populations, particularly pregnant women and infants. J Pediatr Health Care. (2025) 39, 479-488. |
|
05/01/2025 to 06/30/2026 | $0.00 | $10.00 |
|
JPHC CE: Preventing HIV in the Adolescent Population with PrEP: The Role of the Nurse Practitioner 1.0 NAPNAP contact hour of which 1.0 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Preexposure prophylaxis (PrEP) uptake remains low among adolescents and young adults at high risk due to various barriers, such as decreased access to care, human immunodeficiency virus (HIV) stigma, and misinformation. The barriers to the uptake of PrEP among adolescents and young adults are multifaceted and require comprehensive mitigation strategies. Presented is the epidemiology of HIV, pathophysiology, and complications of HIV in adolescents, history of PrEP research, “How to End the HIV Epidemic in the U.S.” plan, reviewing and eliminating barriers to PrEPcare, PrEP curriculum opportunities for the provider, and the role of the nurse practitioner in reducing new HIV diagnoses in adolescents. J pediatr Health Care. (2025) 39, 503−514. |
|
05/01/2025 to 06/30/2026 | $0.00 | $10.00 |
|
Sedation & Analgesia Outside the Box: Choices and Challenges 2024 1.25 NAPNAP Contact Hour of which 1.25 contains pharmacology content and 1.25 is related to controlled substances. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is a recorded presentation for NAPNAP's 2024 National Conference. Pain and sedation management in the pediatric population has traditionally focused on opioids and benzodiazepines, but there are many other options. We will review the benefits of using a multimodal strategy for pain and sedation management, including the use of alternative agents and administration routes, to ensure patient comfort. We will also review side effect prevention, including delirium assessment and management. |
|
06/27/2024 to 06/30/2026 | $12.50 | $25.00 |
|
A New Era in Pediatric Weight Management: Anti-Obesity Medications for Adolescents 2024 1.25 NAPNAP Contact Hour of which 1.0 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is a recorded presentation for NAPNAP's 2024 National Conference. The new AAP guidelines for pediatric obesity management recommend consideration of anti-obesity medication as adjunct treatment. How can pediatric-focused NPs incorporate these agents into their practice? This presentation will review approved medications, and teach learners how to use them safely and competently. |
|
06/27/2024 to 06/30/2026 | $12.50 | $25.00 |